Watson Bio will hold a shareholders meeting on October 13

Every time AI News, Watson Biological (SZ 300142, closing price: 37.33 yuan) issued an announcement on September 27 that on October 13, 2022 (Thursday) at 14:00 pm, the company will be in Wuhua District, Wuhua District, Kunming City, Yunnan Province. The conference room of 110 meters southwest of Haiyuan North Road and Kexin Road held the second interim shareholders meeting in 2022. The shareholders' meeting will review the proposal of the "Proposal about the Company's Board of Directors and the Fifth Board of Directors of the Fifth Board of Directors" and other proposals. Shareholders registered on the spot after receiving the market on September 30, 2022, or vote through the exchange voting system through the exchange system Exercise voting.

From January to June 2022, the operating income of Watson Biological is 98.93%of independent vaccines.

The chairman of Watson Bio is Li Yunchun, male, 60 years old, and his academic background is undergraduate. The president is Jiang Runsheng, male, 65 years old, and his academic background is a PhD.

As of press time, Watson's biological market value was 59.9 billion yuan.

Daeda1997 "Single Stock Trends" reminder:

1. Watson Biology has decreased by 879,200 shares in the northern direction in the past 30 days, and the proportion of circulating shares decreased by 0.06%;

2. In the past 30 days, a total of 1 batch of institutions investigated Watson Biological Survey. The total number of institutions in total survey was one.

For more stock trend information, please search for the WeChat public account "Daida", reply "Query", and receive free query permissions!

Each headline (NBDTOUTIAO) — Li Xiaoyi, chairman of the board of directors of Zhaofe Ophthalmology: The most important thing at the moment is to get the Atto "admission ticket", the new drug company must survive first

(Reporter Zeng Jianhui)

Disclaimer: The content and data of this article are for reference only, and do not constitute investment suggestions. Please verify before use. Based on this, the risk is on its own.

Daily Economic News

- END -